US health regulators have for the first time approved a drug to prevent HIV infection.Truvada can be used by those at high risk of infection and anyone who may engage in sexual activity with HIV-infected partners, said the Food and Drug Administration (FDA). Studies showed the drug reduced the risk of contracting HIV by up to 73%. Some health workers and groups active in the HIV community opposed a green light for the once-daily pill.